Evaluation of Cilostazol in Combination With L-Carnitine in Subjects With Intermittent Claudication.
Phase of Trial: Phase IV
Latest Information Update: 21 May 2013
At a glance
- Drugs Levocarnitine (Primary) ; Cilostazol
- Indications Embolism and thrombosis; Intermittent claudication; Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms ECLECTIC
- 21 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Sep 2009 Planned end date changed from 1 Apr 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 20 Jan 2009 New trial record.